Published in AIDS Weekly, April 24th, 2006
The regimen, consisting of lamivudine/zidovudine fixed dose combination tablets and efavirenz tablets, is for the treatment of HIV-1 infection in adults. It is manufactured by Aurobindo Pharma Ltd. of Hyderabad, India. This is the first co-package of these products that has met the clinical safety and efficacy and the manufacturing quality standards of the FDA.
"The co-packaging of these drugs should make distribution of the drugs easier in many situations and make it easier for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.